Even a politician as tenaciously optimistic as Matt Hancock was struggling to put any positive spin on it: the world has woken up to the disappointing news that trials of the Oxford vaccine for Covid-19 had been paused after an adverse reaction in one patient. The Oxford-AstraZeneca vaccine was one of seven in Phase 3 trials, in which doses are administered to thousands of people of different ages and varying states of health.